INTRODUCTION
Intracellular membrane traffic is an essential process of all mammalian cells. Constitutive membrane traffic is involved in the movement ofmost membrane proteins to particular compartments and organelles, and in steady-state secretion. Regulated membrane traffic is involved in the specific and often acute changes in cellular localization of membrane proteins and the secretion of vesicle contents in response to hormones and other stimuli.
One of the basic steps in intracellular membrane movement is the docking and fusion of a vesicle with a target membrane. Membrane-bound proteins participating in these processes have recently been identified in neuronal tissues and within the Golgi apparatus [1] [2] [3] . These elements can be isolated as a highmolecular-mass (20 S) complex comprising membrane proteins of both the vesicle and the target membranes [2] [3] [4] . Additional components of the complex are ubiquitous cytosolic proteins known to participate in intra-Golgi transport, which include the N-ethylmaleimide-sensitive factor (NSF) and soluble NSF attachment factors (SNAPs) [2, 3] . The membrane proteins on the donor vesicle and the acceptor membrane that constitute the 20 S complex (docking/fusion complex) have been termed SNAP receptors or SNAREs [2] . SNAREs isolated from detergent extracts of mammalian brain include the synaptic vesicle VAMPother internal membrane fractions of mature muscle or muscle cells in culture. Interestingly, both VAMP-2 and cellubrevin were much more abundant in the differentiated L6 myotubes than in their precursor myoblasts, suggesting that they are required for functions of differentiated muscle cells. The identity of both polypeptides was further confirmed by their susceptibility to proteolysis by Clostridium tetanus toxin. Expression of these products was further established by the presence of mRNA transcripts of VAMP-2 and cellubrevin, but not of VAMP-1, in both skeletal muscle and L6 myotubes. In contrast, other synaptic vesicle and docking/fusion components were undetectable, such as VAMP-1, SNAP25 and syntaxin lA/lB, as were synaptophysin and synapsin Ia/lb, proteins which are believed to be involved in sensing the signal for neuronal exocytosis. It is concluded that VAMP-2 and cellubrevin are expressed in skeletal muscle cells and may each participate in specific processes of intracellular membrane traffic. 2 (vesicle-associated membrane protein 2)/synaptobrevin II, while plasma membrane SNAREs include synataxins IA, lB and SNAP25 [2, 4] . A direct interaction between VAMP-2 and syntaxin IA was recently demonstrated in vitro [5] , indicating that these proteins may play a role in the docking and/or the fusion of the vesicle to the membrane.
Recently, VAMP-like molecules were detected in two nonneuronal cells, i.e. rat adipocytes [6] and pancreatic acinar cells [7] . In addition, another member of the VAMP family was identified and named cellubrevin. mRNA transcripts of cellubrevin were detected in testis, lung, kidney, intestine, brain, cerebellum, spinal cord and liver, and the corresponding polypeptide was also detected in parotid, thyroid and adrenal glands [8] . It was thus hypothesized that cellubrevin may play a role in endocytic/exocytic mechanisms. To date, expression of VAMP has been found to be restricted to secretory tissues, whereas cellubrevin is found in both secretory and non-secretory cells. The participation of VAMP in synaptic secretion has been documented, but it is not known if either VAMP or cellubrevin are involved in non-secretory intracellular membrane transit.
Skeletal muscle is a tissue which displays both constitutive and regulated membrane traffic. In particular, membrane structures containing glucose transporters and a2 and fll subunits of the Na+/K+-ATPase are recruited to the plasma membrane by insulin [9] [10] [11] [12] [13] , and cell-surface insulin receptors are increased by adrena- 
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A. Volchuk and others line [14] . The identification of proteins implicated in intracellular traffic at all levels may lead to a better understanding of regulated membrane flux in skeletal muscle. The objective of this study was to determine whether members of the synaptic vesicle docking/fusion apparatus are expressed in mature muscle and in muscle cells in culture. Protein products and mRNA transcripts of the VAMP-2 and cellubrevin genes were detected in these cells and the subcellular distribution of the polypeptides determined. Their identity was confirmed by their susceptibility to proteolysis by tetanus toxin, a clostridial neurotoxin recently shown to specifically cleave cellubrevin and VAMP-2.
EXPERIMENTAL Membrane and tissue fractions
Subcellular fractionation of rat skeletal muscle This was carried out as described previously [9, [15] [16] [17] and the membranes were characterized on the basis of their content of immunodetectable marker proteins and enzymic activities [9, 11, [15] [16] [17] .
Brain microsomes These were prepared according to the procedure of Nagamatsu et al. [18] .
Sciatic nerve extract
The visible portion of the nerve of 250 g rats was excised, cut into small fragments and incubated in 4 % SDS, at pH 7.0, with the protease inhibitors 1 mM phenylmethanesulphonyl fluoride (PMSF), 5 ,uM leupeptin, 5 ,uM pepstatin A, 50 ,uM E-64, and 5 mM EDTA, for 30 min at room temperature. The extract was homogenized with a Wheaton Teflon-glass homogenizer and centrifuged in a microfuge at maximum speed to sediment insoluble material. The supernatant, containing all membrane and cytosolic components, was frozen until used.
Growth, differentiation and subcellular fractionation of L6 muscle cells L6 muscle cells were grown to the stages of myoblasts and myotubes [19] [20] [21] [22] [23] . Membrane fractions of cells at both stages of differentiation were prepared as described previously [19, 20] .
Immunoblots Samples were solubilized in Laemmli's sample buffer [24] , resolved by SDS/PAGE and transfered on to poly(vinylidene difluoride) (PVDF) filters as described [23] . Filters (Amersham) . For alkaline phosphatase detection, the filters were stained with 5-bromo-4-chloro-3-indoyl phosphate-p-toluidine salt and pNitroblue tetrazolium chloride as described [25] . Scanning of X-ray films was done using a PDI model DNA35 scanner with the version 1.3 of the Discovery Series one-dimensional-gelanalysis software.
Antibodies
An antibody specific for the VAMP-2 isoform (named V2R) was generated in rabbits by injecting a synthetic peptide corresponding to the 16 N-terminal amino acids of this protein (MSATAATAPPAAPAGE) coupled to BSA through an Nterminal cysteine residue. The peptide was coupled to maleimideactivated BSA (Pierce) according to manufacturer's instructions. The specificity of the rabbit polyclonal anti-VAMP-2 serum was confirmed by its ability to recognize VAMP-2 expressed as a recombinant fusion protein on Western blots. No cross-reactivity to other members of the VAMP family was detected, or to fusion proteins comprising common regions of the VAMPs including amino acids 33-116. The antibody to cellubrevin was a kind gift from Dr. Thomas C. Sudhof (Howard Hughes Medical Institute, Dallas, TX, U.S.A.) and was raised to the N-terminus segment as reported [8] . Monoclonal antibodies to synaptophysin (clone SY38) and SNAP25 (clone SM181) were obtained from Boehringer-Mannheim and Sternberger Monoclonals Inc. respectively. A monoclonal antibody (number SPM-1) recognizing syntaxins lA and lB [4] was the kind gift of Dr. T. Abe (University of Niigata, Niigata, Japan). A monoclonal antibody recognizing synapsin I (mouse monoclonal hybridoma cell line 97.8B2.4) was the kind gift of Dr. T. Ueda (University of Michigan, Ann Arbor, MI, U.S.A.). A monoclonal antibody directed to the acl isoform of the Na+/K+-ATPase was the kind gift of Dr. K. Sweadner (Harvard University, Boston, MA, U.S.A.) [26] .
Treatment with tetanus toxin Membrane fractions derived from L6 myotubes and rat skeletal muscle respectively were dried down in a speed-vac and resuspended in 20 ,u of potassium glutamate buffer (138 mM potassium glutamate, 20 mM Hepes, 8 Figure 1 also demonstrate that the VAMP-2 polypeptide is considerably more abundant in brain than in muscle. Unfractionated brain microsomes gave an approximately 30-fold higher signal of VAMP-2/mg of protein than did fraction 30, the purified skeletal muscle membranes richest in VAMP-2.
Proteins immunologically related to VAMP-1 and VAMP-2 have been detected in non-neuronal cells [6, 7] but the isotype expressed in these cells was not determined given that the antibodies used to visualize them do not differentiate among the members of the VAMP family. Because the VAMP-2 isotype had previously been shown to be expressed only in neuronal cells and neuroendocrine cells, we explored the possibility that some, or all, of the VAMP-2 present in the muscle fractions might originate from ancillary tissues. The membrane fractions isolated from skeletal muscle were previously shown to be devoid of neuronal markers, based on lack of the Oc3 subunit of the Na+/K+-ATPase (Y. Mitsumoto, H. Hundal and A. Klip, unpublished work) and of endothelial markers [17] . We further explored whether sciatic nerve contains VAMP-2 which might contaminate the musclederived fractions. Figure 1 ( figure, while the reverse applies to Figure 2 ). After electrotransfer, PVDF filters were cut as described in Figure 2 and immunoblotted for al Na+/K+-ATPase (top portion) or cellubrevin (bottom portion). Immunoreactive bands were detected by 1251-labelled sheep anti-(mouse IgG) antibodies (top) or the enhanced chemiluminescence method (bottom) as outlined in the Experimental section.
porter and the voltage-sensitive Ca2' channel [21] [22] [23] . Two clearly identifiable membrane fractions were analysed: one, banding on top of 320 sucrose, which is enriched in plasma membranes [19, 20] but may also contain endosomes (PM fraction), and a second, light microsomal (LM) fraction, which has been shown to contain the donor pool of GLUT4 glucose transporters [19] [20] [21] . The fractions were further characterized in Figure 2 by the presence of the a.l subunit of the Na+/K+-ATPase, which segregates with the PM fraction and whose content does not change during maturation from myoblasts to myotubes. Figure  2 demonstrates that whereas the VAMP-2 polypeptide was not visualized in either of the two membrane fractions derived from Figure 3 cellubrevin immunoreactivity in isolated membranes of rat skeletal muscle, but interestingly not in crude brain microsomes. This is in contrast with VAMP-2, which was shown above to be more abundant in brain microsomes than in the muscle membranes. Given the rather impure nature of the brain microsomes compared with the purified muscle membranes, it cannot be ruled out that cellubrevin may be expressed in brain cells albeit at much reduced levels. Indeed, cellubrevin mRNA has been found in brain RNA [8] . In tissues where the cellubrevin polypeptide has been detected, this required extraction of the samples with Triton X-1 14 [8] . In contrast, the muscle membrane fractions used in the present study are of sufficient purity to allow detection without the need for detergent extraction. Results from three independent experiments showed that the relative distribution of cellubrevin in fractions 25:30:35 was 1.0: 1.8:0.22. This distribution of the 17 kDa cellubrevin in skeletal muscle closely parallels that of the 18 kDa VAMP-2. Figure 3 also shows that cellubrevin is expressed in membranes of L6 muscle cells in culture. As is the case for VAMP-2, cellubrevin was found to be highly concentrated in the PM fraction, and largely depleted from the LM fraction (the relative proportion in three separate experiments averaged 0.13: 1.0 for LM: PM). However, in contrast with VAMP-2, cellubrevin was clearly detectable in L6 cells even at the myoblast stage (PM fraction), and its content further increased in the myotubes, where LM localization also became apparent. In addition, cellubrevin was found to be more abundant in membranes from L6 myotubes than in the cognate fraction of mature rat muscle (notice the difference in intensity of the bands in Figure 3 , using 30 ,ug and 50 ,tg of protein of L6 and rat muscle membranes respectively).
The relative roles of VAMP-2 and cellubrevin within muscle cells remain to be determined, but it may be hypothesized that, as suggested by recent studies [2, 8] , each participates in specific membrane docking/fusion processes. Interestingly, although cellubrevin is present in hepatic endosomes, it does not appear to mediate endosome-endosome fusion assayed in vitro [30] .
Susceptibility of VAMP-2 and cellubrevin to proteolysis by tetanus toxin Both VAMP-2 and cellubrevin have been found to be specifically cleaved by the endopeptidase activity of the catalytic chain of L6 myoblasts, it was clearly detectable in the membranes from tetanus toxin [8, 31] . To confirm that the polypeptides identified in our study by the VAMP-2-specific and cellubrevin-specific antibodies were indeed the corresponding antigens, we assessed the integrity of the immunoreactive bands following in vitro treatment of isolated membranes with tetanus toxin light chain. Figure 4 shows clear reductions in the amount of immunoreactivity with both the anti-VAMP-2 antibody and the anticellubrevin antibody in both skeletal muscle and L6 myotube membranes. Triton X-100 was used to facilite hydrolysis of VAMP-2 and cellubrevin by the toxin. The detergent was previously used in studies in vitro of Clostridium toxin action [32] and may increase accessibility of the substrate to the enzyme. The Coomassie Blue staining pattern of other polypeptides of the membrane fractions in Figure 4 was not altered by treatment with the toxin (results not shown), indicating that there was no random hydrolysis of proteins by the light-chain enzyme. Figure  4 (a) shows complete cleavage of the 18 kDa band recognized by the anti-VAMP-2 antibody in skeletal muscle by 50 nM tetanus toxin. Although cleavage was substantial in L6 myotubes, the remnant immunoreactive band could suggest the presence of an unknown, toxin-resistant isoform of VAMP. Figure 4(b) shows, however, that all immunoreactivity disappeared upon in vitro treatment of L6 myotube membranes with a higher concentration of the clostridial toxin (90 nM), demonstrating that all the immunoreactivity was toxin-sensitive and thus most likely to be VAMP-2. This concentration of the toxin also fully cleaved cellubrevin in both skeletal muscle and L6 myotubes (Figure 4c ).
Test of expression of synaptophysin, SNAP25, syntaxin 1A/1B and synapsin la/lb in skeletal muscle and L6 myotubes To investigate whether muscle cells express other proteins thought to be required for synaptic vesicle fusion in nerve cells, we examined the presence in muscle and L6 myotube membranes of two other proteins involved in vesicle docking/fusion, i.e. SNAP25 and syntaxin lA/I B, which are known to be membrane proteins of the presynaptic membrane. In addition, the presence of two synaptic vesicle proteins, synapsin I and synaptophysin, was also explored in the muscle membranes. Synapsin I is a synaptic vesicle-associated protein which becomes phosphorylated in response to agonist stimulation of neuronal cells [33] , and has been proposed to mediate synaptic vesicle sequestration [33] or to inhibit excess neurotransmitter release by residual Ca2l [34] . Synaptophysin is an integral membrane glycoprotein of synaptic vesicles, ofno known function [35] . Figure 5 Detection of VAMP-2 mRNA in mature muscle and muscle cells in culture
The results from Figures 1-5 strongly suggest that VAMP-2 and cellubrevin are expressed at the protein level in skeletal muscle and muscle cells in culture. This is the first demonstration of expression of these two members of the VAMP family in nonneuronal tissues, given the fact that the isoform expressed in fat cells has not been identified [6] and the isoform expressed in acinar cells is thought to be VAMP-i [7] . The conclusion of our study is based on the isoform-specificity of the antibodies used, and on the susceptibility of the rat VAMP-2 and cellubrevin, but not of VAMP-1, to proteolysis by tetanus toxin. However, final demonstration of the expression of these gene products in skeletal muscle cells requires detection of their mRNA transcripts. Indeed, the use of cDNA probes on Northern blots is a more stringent approach than the use of antibodies on immunoblots. (Figure 6b ). Total RNA of L6 myotubes also showed detectable levels of VAMP-2 mRNA. These results confirm the known absence of VAMP-1 from skeletal muscle [36] and reveal the expression of the VAMP-2 gene product in muscle RNA extracts and in differentiated muscle cells. Figure 6(c) shows that the 1.8 kb mRNA of cellubrevin was clearly detectable in skeletal muscle RNA and in L6 myotubes.
In conclusion, the present study demonstrates that both VAMP-2 and cellubrevin are expressed in skeletal muscle and muscle cells in culture. Both proteins increase substantially upon muscle cell differentiation, suggesting that they may participate in membrane traffic processes particular to the muscle phenotype. Whereas VAMP-2 is not expressed in myoblasts, cellubrevin is already present at this stage in muscle development. The peak level of expression of both proteins occurred in the myotube stage, possibly suggesting an important developmental role for the protein. Furthermore, the absence of SNAP25, synaptomolecular mechanisms controlling regulated exocytosis in muscle cells are different from those of neurons. The role of VAMP-2 and cellubrevin in mediating intracellular traffic events, and in particular in regulated membrane fusion, can now be examined. Studies are currently underway to evaluate the sensitivity of insulin-mediated recruitment of glucose transporters to tetanus toxin, in order to assess the possible contributions of VAMP-2 and cellubrevin to the process of regulated membrane traffic in muscle cells.
